Conférences  >  Médecine & Soins de Santé  >  Pharmacogénétique, Médecine personnalisée

European Molecular Biology Organization – EMBO

The discovery of myriad noncoding RNAs (ncRNAs) over the past decade has revealed a universe of new and exciting therapeutic opportunities. Many thousands of microRNAs, piRNAs, circular RNAs, long noncoding RNAs, and others are expressed across healthy and diseased human tissues and play key functional roles in pathogenic states and processes. Their regulatory roles, cell-type-specificity, and vast numbers confer on ncRNAs unique advantages as therapeutic targets. Rapid advances in clinical transcriptomics, oligonucleotide therapeutics, and RNA-directed small molecules, open the possibility for rapid, economical, and personalised ncRNA-directed therapies. Reaching this goal will require overcoming key challenges, including low evolutionary conservation in model species, poorly-characterised molecular mechanisms, finding hits amongst the vast ncRNA transcriptome, and effectively drugging targets in vivo. This EMBO Workshop will bring together colleagues from both academic and commercial worlds to discuss their latest progress in these issues. Sessions will cover the full span from basic disease biology to therapeutic development. Confirmed speakers represent leaders from around the globe, and numerous slots have been set aside for oral presentations selected from submitted abstracts.

Cancérologie,    Médecine translationnelle, essais cliniques

SRH Wald-Klinikum Gera GmbH, SRH Hochschule für Gesundheit, Medizinische Hochschule Hannover, event lab. GmbH

Gewichtsspektrumstörungen – von extremem Untergewicht bis hin zu extremem Übergewicht – gehen häufig mit Essstörungen einher oder sind durch diese bedingt. Unter dem Motto „Das breite Spektrum der Ess- und Gewichtsstörungen: Was bleibt – was kommt – was ist neu?“ bietet der gemeinsame Kongress von DAG und DGESS eine attraktive Plattform für den interdisziplinären Austausch. Mit einem wissenschaftlichen Fokus auf der Prävention, Früherkennung, Diagnostik und Therapie von Essstörungen wird der 8. wissenschaftliche Kongress der DGESS die Themen der 39. Jahrestagung der DAG sinnvoll ergänzen.

event lab. GmbH;     Tél.: [+49 (0)341 30 88 84-89];     Email.: tbaehr@eventlab.org

Essstörungen, Adipositas, Ess- und Gewichtsstörungen, Interdisziplinäre Kenntnisse, Behandlung, Gewichtsspektrumstörungen, Forschung, Studien

Génétique et maladie génétique,    Médecine translationnelle, essais cliniques

ESMO - European Society for Medical Oncology

MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalised medicine. The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology will welcome delegates for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

MAP Congress Team;     Tél.: [+41919731947];     Email.: map@esmo.org

oncology, personalised medicine, precision medicine, translational research, molecular characterisation, clonal evolution, cancer profiling, metastatic dissemination, biomarkers, targeted therapeutics

Cancérologie,    Médecine translationnelle, essais cliniques

Infonet

5th International Pharmaceutical Conference and Expo welcomes you as our guest to the City of Baltimore, USA during October 05-06, 2023. The theme of the upcoming edition of iPharma USA is Bridging Pharma Research with Industry.

Tél.: [6193784793];     Email.: anna@ipharmaconference.net

Pharma conference, pharmaceutical event, pharma congress, pharma expo, pharma conference USA, pharmaceutical event, pharma USA, pharmaceutical expo, international pharma, iPharma USA, Pharma USA, iPharma 2023, pharma conference USA, pharma event USA, pharma event USA, pharma business USA, iPharma register, pharma abstract, Drug Discovery, Drug Delivery Systems, Pharmaceutical Nanotechnology, Drug Therapy, Pharmaceutical Formulations, Clinical Trials, Neuropharmacology, Biopharmaceutical, Nutraceuticals, Pharma Medicines

ESMO - European Society for Medical Oncology

The ESMO Asia Congress 2023 will welcome you in Singapore from 1 to 3 December, to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level, and for the Asia-Pacific region. The outstanding scientific programme will cover the latest advances on the most prevalent cancer types in the region, offering high quality multidisciplinary educational sessions and special sessions in collaboration with illustrious international and Asia-Pacific oncology associations.

As usual, there will be a special focus on the Pan-Asian Guidelines Adaptation (PAGA) Lectures, conceived to share best practice standards of care for cancer patients and providing a framework for the structured interaction of key opinion leaders in oncology from Asia and Europe.

We hope you will be part of that journey by attending ESMO Asia 2023, where we will unite the Asian and global oncology community and share unforgettable moments!

Email.: asiacongress@esmo.org

Breast cancer, CNS, Developmental and precision medicine, gastrointestinal tumours, genitourinary tumours, gynaecological malignancies, head and neck cancer, investigational immunotherapy, melanoma, public policy, sarcoma, rare tumours, thoracic cancer, oncology

Cancérologie,    Médecine translationnelle, essais cliniques